Klebsiella oxytoca clinical isolate A was recovered from the urine of a 55-year-old man with prostatic and urinary tract infections. This isolate displayed a -lactam resistance phenotype consistent with overproduction of a chromosomally encoded class A -lactamase and had decreased susceptibilities to all -lactams except ceftazidime, cephamycins, and carbapenems. Four weeks after treatment with an antibiotic regimen that included ceftazidime, K. oxytoca isolate B, which had a high level of resistance to ceftazidime, was isolated from the urine of the same patient. Isoelectric focusing analysis of the culture extracts of these isolates gave a pI of 5.4 for both isolates. Cloning experiments with the PCR products of the bla OXY gene resulted in two Escherichia coli DH10B recombinant clones with resistance phenotypes mirroring those of the parental isolates. Sequencing analysis revealed that the bla OXY-2-5 gene from K. oxytoca B had a single nucleotide substitution compared to the sequence of the bla OXY-2 gene from K. oxytoca A, leading to a proline-to-serine substitution at position 167, according to the numbering of Ambler. Biochemical analysis of purified OXY-2-5 showed that it had the ability to hydrolyze ceftazidime. This is the first report of in vivo selection of a K. oxytoca isolate that produced a chromosomally encoded -lactamase conferring resistance to ceftazidime.Klebsiella oxytoca is a gram-negative rod of the family Enterobacteriaceae that is responsible for nosocomial infections, mainly located in the urinary tract. In wild-type K. oxytoca, a penicillinase is produced at low levels and confers resistance to aminopenicillins, ticarcillin, and piperacillin. Clinical isolates of K. oxytoca resistant to expanded-spectrum cephalosporins and aztreonam have been reported (13,14). Two mechanisms of resistance to these expanded-spectrum -lactams have been reported for K. oxytoca. Overproduction of the chromosomally encoded penicillinase due to mutation in the promoter region of the gene may appear (9), whereas production of a plasmidmediated extended-spectrum -lactamase has also been reported (19). The former mechanism confers resistance to most penicillins and reduced susceptibility to most cephalosporins but does not confer resistance to either cephamycins (such as cefoxitin) or ceftazidime. DNA sequencing shows that K. oxytoca chromosomal -lactamase genes may be divided into two main groups, the bla OXY-1 and bla OXY-2 genes (11). These two types of -lactamase genes share 89.7% DNA identity and confer the same phenotype of resistance to -lactams. Biochemical study of the purified chromosomally encoded -lactamase OXY-2 showed that this enzyme exhibits an extended spectrum of activity (2), leading to its classification in functional group 2be of the extended-spectrum -lactamases (6).In this study, we report on the biochemical analysis of an OXY-2 variant that conferred resistance to ceftazidime and that was obtained after in vivo selection.
MATERIALS AND METHODSBacterial strains and plasmids. Cli...